Liu, P., Yang, S., Li, F., Sun, X., Li, W., Liu, Y., Wang, L., Huang, L., Qin, L., Qian, W., Su, L., Cai, Q., Tan, X., Yang, W., Jia, M., Liu, N., Lou, Y., Shen, Y., Tan, F., Shi, Y. (2026). ROCK-2: An ongoing open-label, randomized, multicenter phase 2 study of rocbrutinib versus investigator's choice of therapy in patients with R/R non-GCB DLBCL.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps7106